Sarepta Therapeutics
SRPT
#2152
Rank
โ‚น620.76 B
Marketcap
โ‚น6,398
Share price
0.88%
Change (1 day)
-38.48%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Revenue for Sarepta Therapeutics (SRPT)

Revenue in 2024 (TTM): โ‚น160.32 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น164.20 Billion. an increase over the revenue in the year 2023 that were of โ‚น103.50 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sarepta Therapeutics from 1997 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น163.16 B57.64%
2023 โ‚น103.50 B34.06%
2022 โ‚น77.20 B47.79%
2021 โ‚น52.24 B32.26%
2020 โ‚น39.49 B45.45%
2019 โ‚น27.15 B29.02%
2018 โ‚น21.04 B113.26%
2017 โ‚น9.87 B2579.36%
2016 โ‚น0.36 B342.41%
2015 โ‚น83.26 M-86.53%
2014 โ‚น0.61 B-29.61%
2013 โ‚น0.87 B-57.02%
2012 โ‚น2.04 B-17.78%
2011 โ‚น2.48 B88.55%
2010 โ‚น1.31 B61.54%
2009 โ‚น0.81 B-20.13%
2008 โ‚น1.02 B137.01%
2007 โ‚น0.43 B8342.88%
2006 โ‚น5.1 M-97.63%
2005 โ‚น0.21 B1054.73%
2004 โ‚น18.64 M-57.78%
2003 โ‚น44.15 M10.04%
2002 โ‚น40.12 M17.78%
2001 โ‚น34.07 M-43.73%
2000 โ‚น60.54 M596.4%
1999 โ‚น8.69 M-48.88%
1998 โ‚น17 M44.26%
1997 โ‚น11.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.482 T 1,411.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น58.89 B-64.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.94 B-99.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น38.91 B-76.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น194.10 B 18.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น69.65 B-57.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31.40 B-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA